News
GLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...
A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...
16h
Investor's Business Daily on MSNObesity Newcomer Metsera, Up 23%, Enters The Ring With A PunchMetsera stock surged Monday after the drugmaker unveiled "solid" results for a potential monthly shot to stoke weight loss.
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...
Obesity — like most other medical conditions — requires an “arsenal” of treatments, rather than a one-size-fits-all approach.
A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the ...
Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results